919 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Friday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Teva Pharmaceuticals Had a Very Bad Day, in a Very Bad Year https://www.fool.com/investing/2017/08/07/teva-pharmaceuticals-had-a-very-bad-day-in-a-very.aspx?source=iedfolrf0000001 Aug 07, 2017 - The generic drugmaker lost 20% of its market cap last Thursday after a quarterly report that was heavy on bearish news.
Teva: A Sign Of Things To Come https://seekingalpha.com/article/4095954-teva-sign-things-come?source=feed_sector_healthcare Aug 07, 2017 - teva cut its dividend while its payout ratio indicates that this was unnecessary.This indicates that management sees more trouble down the road.This could provide an extra incentive for Allergan to se
Teva sells Paragard asset to CooperSurgical for $1.1B https://seekingalpha.com/news/3294738-teva-sells-paragard-asset-coopersurgical-1_1b?source=feed_news_all Sep 11, 2017 - Teva Pharmaceutical Industries (NYSE:TEVA) inks an agreement with CooperSurgical to sell PARAGARD (intrauterine copper contraceptive) for $1.1B in cash. The deal includes Teva's manufacturing site in
Teva: Caution Is Warranted https://seekingalpha.com/article/4106278-teva-caution-warranted?source=feed_sector_healthcare Sep 12, 2017 - Teva closed 19% higher following the announcement of an industry veteran, Kare Schultz, as the incoming president and chief executive officer.The share price continued its march upwards the next day a
Teva Pharmaceutical shares jump after Goldman upgrades embattled drugmaker, predicts turnaround https://www.cnbc.com/2017/12/15/teva-pharmaceutical-shares-jump-after-goldman-upgrades-embattled-drug-maker-predicts-turnaround.html Dec 15, 2017 - Goldman Sachs raises its rating to buy from neutral for the generic drugmaker.
Here's How Much Teva Pharmaceutical Could Net From the Sale of Non-Core Assets https://www.fool.com/investing/2017/05/12/heres-how-much-teva-pharmaceutical-could-net-from.aspx?source=iedfolrf0000001 May 12, 2017 - Teva's Women's Health operations and its European oncology and pain divisions appear to be on the chopping block.
Jim Cramer Weighs In On Under Armour, Walgreens And Teva Pharmaceutical http://feeds.benzinga.com/~r/benzinga/~3/6MYDZFMhDps/jim-cramer-weighs-in-on-under-armour-walgreens-and-teva-pharmaceutical Jun 14, 2017 -

On CNBC's "Mad Money", Jim Cramer said that Under Armour Inc (NYSE: UAA) had a nice move higher and it could pull back a bit. He thinks the apparel sector isn't that bad.

read more

Teva to nominate new directors https://seekingalpha.com/news/3272529-teva-nominate-new-directors?source=feed_news_all Jun 09, 2017 - In the latest step toward remaking the company, Teva Pharmaceutical (NYSE:TEVA) will seek to overhaul its board by nominating four new directors.Among their first orders of business would be picking a
4 Pressing Questions We Want Answered When Teva Pharmaceutical Reports Tomorrow Morning https://www.fool.com/investing/2017/05/10/4-pressing-questions-we-want-answered-when-teva-ph.aspx?source=iedfolrf0000001 May 10, 2017 - From Copaxone's patents to its $35.8 billion in debt, shareholders have questions and we want answers.
3 Reasons Teva Pharmaceutical Industries Ltd. Nosedived 12% in May https://www.fool.com/investing/2017/06/06/3-reasons-teva-pharmaceutical-industries-ltd-nosed.aspx?source=iedfolrf0000001 Jun 06, 2017 - Teva's rough year continues to get worse. Is there light at the end of the tunnel?

Pages: 12345678910...92

<<<Page 5>